Guggenheim Capital’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-52,980
| Closed | -$2.43M | – | 2320 |
|
2018
Q3 | $2.43M | Buy |
52,980
+3,991
| +8% | +$183K | 0.02% | 1130 |
|
2018
Q2 | $2.9M | Buy |
48,989
+7,505
| +18% | +$444K | 0.02% | 1027 |
|
2018
Q1 | $2.82M | Buy |
41,484
+5,359
| +15% | +$365K | 0.01% | 1393 |
|
2017
Q4 | $3.57M | Sell |
36,125
-6,324
| -15% | -$625K | 0.01% | 1235 |
|
2017
Q3 | $5.08M | Sell |
42,449
-3,501
| -8% | -$419K | 0.01% | 1052 |
|
2017
Q2 | $4.02M | Sell |
45,950
-12,031
| -21% | -$1.05M | 0.01% | 1142 |
|
2017
Q1 | $2.16M | Buy |
57,981
+250
| +0.4% | +$9.3K | 0.01% | 1607 |
|
2016
Q4 | $1.77M | Buy |
57,731
+5,784
| +11% | +$178K | 0.01% | 1777 |
|
2016
Q3 | $3.48M | Buy |
51,947
+40,392
| +350% | +$2.71M | 0.01% | 1238 |
|
2016
Q2 | $344K | Sell |
11,555
-57,377
| -83% | -$1.71M | ﹤0.01% | 2503 |
|
2016
Q1 | $2.03M | Buy |
68,932
+15,217
| +28% | +$447K | 0.01% | 1559 |
|
2015
Q4 | $4.21M | Buy |
53,715
+13,528
| +34% | +$1.06M | 0.01% | 1100 |
|
2015
Q3 | $3.03M | Sell |
40,187
-52,038
| -56% | -$3.92M | 0.01% | 1309 |
|
2015
Q2 | $10.8M | Buy |
92,225
+44,255
| +92% | +$5.17M | 0.03% | 800 |
|
2015
Q1 | $11.3M | Buy |
47,970
+997
| +2% | +$235K | 0.03% | 806 |
|
2014
Q4 | $8.89M | Buy |
46,973
+13,348
| +40% | +$2.53M | 0.02% | 877 |
|
2014
Q3 | $8.02M | Sell |
33,625
-34,296
| -50% | -$8.18M | 0.02% | 978 |
|
2014
Q2 | $4.48M | Buy |
67,921
+8,061
| +13% | +$532K | 0.01% | 1231 |
|
2014
Q1 | $6.23M | Buy |
59,860
+13,016
| +28% | +$1.36M | 0.02% | 1028 |
|
2013
Q4 | $4.85M | Buy |
+46,844
| New | +$4.85M | 0.01% | 1098 |
|